These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2266458)

  • 21. Assessment of proliferative activity in Wilms' tumour.
    Delahunt B; Farrant GJ; Bethwaite PB; Nacey JN; Lewis ME
    Anal Cell Pathol; 1994 Aug; 7(2):127-38. PubMed ID: 7993823
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Demonstration of the nucleolar organizer region by silver staining (AgNOR method) in research and in histopathological practice.
    Kodousek R; Dusek J
    Acta Univ Palacki Olomuc Fac Med; 1991; 131():9-37. PubMed ID: 1726500
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Argyrophilic nucleolar organizer region in proliferating cell has a predictive value for local recurrence in superficial bladder tumor.
    Tomobe M; Shimazui T; Uchida K; Hinotsu S; Akaza H
    J Urol; 1999 Jul; 162(1):63-8. PubMed ID: 10379741
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The utility of Ki67 immunostaining, nuclear organizer region counting, and morphology in the assessment of follicular lymphomas.
    Cibull ML; Heryet A; Gatter KC; Mason DY
    J Pathol; 1989 Jul; 158(3):189-93. PubMed ID: 2475600
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correlation between nucleolar organizer regions visualized by silver staining and the growth rate in lung adenocarcinoma.
    Ogura S; Abe S; Sukoh N; Kunikane H; Nakajima I; Inoue K; Kawakami Y
    Cancer; 1992 Jul; 70(1):63-8. PubMed ID: 1606548
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of proliferating cell nuclear antigen (PCNA) and nucleolar organizer regions (NORs) in multiple myeloma.
    Skopelitou A; Tselenis S; Theocharis S; Agnantis N; Tsenga A; Elemenoglou J; Hadjiyannakis M; Kittas C
    Anticancer Res; 1994; 14(3A):787-92. PubMed ID: 7915507
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nucleolar organizer regions in cutaneous tumours.
    Egan MJ; Crocker J
    J Pathol; 1988 Mar; 154(3):247-53. PubMed ID: 2450982
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Breast carcinoma kinetics. Argyrophilic nucleolar organizer region counts correlate with Ki67 scores.
    Dervan PA; Gilmartin LG; Loftus BM; Carney DN
    Am J Clin Pathol; 1989 Oct; 92(4):401-7. PubMed ID: 2552790
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Argyrophilic nucleolar organizer regions and proliferating cell nuclear antigen/cyclin in Kaposi's sarcoma. Comparison with morphology and with immunoperoxidase staining for factor VIII-related antigen.
    Haupt HM; Stern JB; Multhaupt H; Newman HW
    Arch Pathol Lab Med; 1995 Jun; 119(6):538-41. PubMed ID: 7605171
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interest of targeting AgNORs measurement in cycling cells: in vivo cell kinetic evaluation of non-small cell lung cancer.
    Bigras G; Marcelpoil R; Brambilla E; Brugal G
    Anal Cell Pathol; 1996 Aug; 11(3):183-98. PubMed ID: 8888954
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Variations in the occurrence of silver-staining nucleolar organizer regions (AgNORs) in non-proliferating and proliferating tissues.
    Leek RD; Alison MR; Sarraf CE
    J Pathol; 1991 Sep; 165(1):43-51. PubMed ID: 1955934
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Argyrophilic nucleolar organiser regions (AgNORs) in breast lesions.
    Dasgupta A; Ghosh RN; Sarkar R; Laha RN; Ghosh TK; Mukherjee C
    J Indian Med Assoc; 1997 Sep; 95(9):492-4. PubMed ID: 9529579
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Argyrophilic nuclear organizer regions in nasopharyngeal carcinoma and paraneoplastic epithelia.
    Chen M; Lee JC; Lo S; Shen J
    Head Neck; 2003 May; 25(5):395-9. PubMed ID: 12692877
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proliferative potential of human brain tumours as assessed by nucleolar organizer regions (AgNORs) and Ki67-immunoreactivity.
    Plate KH; Rüschoff J; Behnke J; Mennel HD
    Acta Neurochir (Wien); 1990; 104(3-4):103-9. PubMed ID: 1701284
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of the argyrophilic nucleolar organizer regions in tumor detection and prognosis.
    Pich A; Chiusa L; Margaria E
    Cancer Detect Prev; 1995; 19(3):282-91. PubMed ID: 7750118
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sequential demonstration of nucleolar organizer regions and Ki67 immunolabelling in non-Hodgkin's lymphomas.
    Janmohamed RM; Murray PG; Crocker J; Leyland MJ
    Clin Lab Haematol; 1990; 12(4):395-9. PubMed ID: 2081380
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combined immunocytochemistry and nucleolar organizer region staining: some technical aspects.
    McMeekin W; Kennedy A; McNicol AM
    Med Lab Sci; 1989 Jan; 46(1):11-5. PubMed ID: 2476643
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic value of AgNOR method in thyroid cytopathology: correlation with morphometric measurements.
    Solymosi T; Tóth V; Sápi Z; Bodó M; Gál I; Csanádi L
    Diagn Cytopathol; 1996 Mar; 14(2):140-4. PubMed ID: 8964170
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cell proliferation in intracranial tumours: selective silver staining of nucleolar organizer regions (AgNORs). Application to surgical and experimental neuro-oncology.
    Plate KH; Rüschoff J; Mennel HD
    Neuropathol Appl Neurobiol; 1991 Apr; 17(2):121-32. PubMed ID: 1713308
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Standardized demonstration of silver-stained nucleolar organizer regions-associated proteins in archival oral squamous cell carcinomas and adjacent non-neoplastic mucosa.
    Piffkò J; Bànkfalvi A; Ofner D; Rasch D; Joos U; Schmid KW
    Mod Pathol; 1997 Feb; 10(2):98-104. PubMed ID: 9127314
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.